Literature DB >> 20975069

Another step toward the cure of metastatic renal cell carcinoma?

Nicholas J Vogelzang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20975069     DOI： 10.1200/JCO.2010.31.5044

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

1.  A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802.

Authors:  Naomi B Haas; Xinyi Lin; Judith Manola; Michael Pins; Glenn Liu; David McDermott; David Nanus; Elisabeth Heath; George Wilding; Janice Dutcher
Journal:  Med Oncol       Date:  2011-02-06       Impact factor: 3.064

Review 2.  Update on targeted therapies for clear cell renal cell carcinoma.

Authors:  Eric A Singer; Gopal N Gupta; Ramaprasad Srinivasan
Journal:  Curr Opin Oncol       Date:  2011-05       Impact factor: 3.645

3.  Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor-targeted therapy.

Authors:  Daniel C Cho; Thomas E Hutson; Wolfram Samlowski; Peter Sportelli; Brad Somer; Paul Richards; Jeffrey A Sosman; Igor Puzanov; M Dror Michaelson; Keith T Flaherty; Robert A Figlin; Nicholas J Vogelzang
Journal:  Cancer       Date:  2012-06-06       Impact factor: 6.860

4.  Survival outcomes for advanced kidney cancer patients in the era of targeted therapies.

Authors:  Arpit Rao; Charles Wiggins; Richard C Lauer
Journal:  Ann Transl Med       Date:  2018-05

5.  Molecular subtyping of metastatic renal cell carcinoma: implications for targeted therapy.

Authors:  Lisha Wang; Sean R Williamson; Mingsheng Wang; Darrell D Davidson; Shaobo Zhang; Lee Ann Baldridge; Xiang Du; Liang Cheng
Journal:  Mol Cancer       Date:  2014-02-26       Impact factor: 27.401

6.  The network of DAB2IP-miR-138 in regulating drug resistance of renal cell carcinoma associated with stem-like phenotypes.

Authors:  Eun-Jin Yun; Jer-Tsong Hsieh; Jiancheng Zhou; Chun-Jung Lin; Shan Xu; John Santoyo; Elizabeth Hernandez; Chih-Ho Lai; Ho Lin; Dalin He
Journal:  Oncotarget       Date:  2017-05-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.